SEC Form 4 · accession 0001704739-17-000015
IRIDEX CORP · IRIX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Atabak Mokari
Officer — CFO and VP Corp Development
Period of report
Jul 24, 2017
Accepted (ET)
Jul 26, 2017 · 9:55 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001006045
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 24, 2017 | A | 6,000 | $9.54 | A | 71,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option Right to BuyF2,F3 | $9.54 | Jul 24, 2017 | M | 63,000 | A | — | Jul 24, 2024 | Common Stock | 63,000 | 63,000 | D |
Explanation of responses
- F1Restricted stock units vest over a period of 48 months with 1/4th of the total number of units vesting on the first anniversary of the grant date and 1/48th of the total number of units vesting each month thereafter. Restriced stock units convert into common stock on a one-for-one basis.
- F2This option was granted pursuant to IRIDEX Corporation's 2008 Equity Incentive Plan and is exempt to Rule 16b-3.
- F3Shares subject to the option vest over a period of 48 months with 1/4th of the total number of shares vesting on the first anniversary of the grant date and 1/48th of the total number of shares vesting each month thereafter.